Radiotherapy Market accounted 6077.8 USD million in 2020 and is expected to reach 11091.6 USD million by 2030 growing with a CAGR of 6.2% during the forecast period. Radiotherapy is a branch of medicine that deals with treatment of cancer which uses high energy beams to kill cancer cells and shrink tumours. It can also be used in combination with surgery, chemotherapy or immunotherapy. Radiotherapy can be used at three levels of cancer treatment including primary cancer treatment, adjuvant therapy after chemotherapy or surgery, and as palliative therapy to shrink the size of tumours and to suppress the symptoms. As of 2015, the cancer death rate had fallen 26% from its peak in 2009.This decline shows death rate reduction to nearly 2.4 million deaths during this period. Furthermore, according to the research study more than 16.9 million Americans diagnosed with cancer were alive in 2019, and this number is expected to reach more than 22.1 million by 2026.

Market Segmentation:

Global radiotherapy market is segmented into product, application, technology and by regions. Based on by product it is classified into external beam radiation therapy, internal radiation therapy/ brachy therapy and systemic radiation therapy. Based on by technology it is segmented into image guide radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), proton beam therapy, 3d conformal radiotherapy (3d CRT), and among others. Based on application, the market is characterized into breast cancer, lung cancer, colorec tal cancer, cervical and among others. And based on region it is segmented into North America, Europe, Asia Pacific, and RoW.

Market Dynamics and Factors:

Technological advancements such as IMRT (intensity modulated radiotherapy), gamaknife, tomotherapy integrated with radiotherapy has positively influenced the market growth. Furthermore, innovation of 3D CRT, has opened effective treatment option with minimal adverse effect in treatment of cancer. Due to rise in number of cancer patients, increase in geriatric population, rise in government initiatives for the adoption of radiotherapy device, are some of the major factors driving the market growth. Moreover, introducing the treatment of cervical and primary peritoneal in gynaecological cancer surgeries, branchy therapy, and cyber knife also helps to expand the market growth. In addition to this, pep test in gynaecology and cyber knife examination in robotic surgeries are contributing as future opportunities for market growth during the forecast period. However lack of trained manpower, cost of equipment are hindering the growth of market.  

Geographic Analysis:

North America is dominating the market, due to increased number of cancer cases and technological advancement in radiotherapy like cyber knife, 3D-CRT, IMRT and among others. Additionally, presence of major companies like GE Healthcare, Varian Medical Systems. Inc., and Covic will impact the market growth. Asia-pacific is expected to emerge as the fastest growing region in terms of market share due to increase in cases of cancer along with geriatric population, and by improving healthcare infrastructure and services in rural area

Competitive Scenario:

Some of the key players of market are GE Healthcare, Siemens Ag, Varian Medical System, Inc. Nordion, Covic, Isoray Medical Inc. Elekta AB. Ion Beam application, Lanon Medical Systems Corporation, Mevion medical System, Inc.

Radiotherapy Market Report Scope